Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Buy
1,126
+8
+0.7% +$1.96K 0.01% 667
2025
Q4
$283K Buy
1,118
+38
+4% +$9.54K 0.01% 580
2025
Q3
$267K Sell
1,080
-30
-3% -$7.18K 0.01% 664
2025
Q2
$267K Buy
1,110
+13
+1% +$3.03K 0.01% 639
2025
Q1
$249K Buy
1,097
+9
+0.8% +$1.98K 0.01% 629
2024
Q4
$224K Sell
1,088
-55
-5% -$12.1K 0.01% 667
2024
Q3
$277K Sell
1,143
-7
-0.6% -$1.64K 0.01% 613
2024
Q2
$252K Buy
1,150
+69
+6% +$15K 0.01% 607
2024
Q1
$243K Buy
+1,081
New +$244K 0.01% 636

Other funds holding STE

Bailard's STE Position: Q1 2026 in Review

Bailard increased its Steris (STE) stake by 0.72% in Q1 2026, buying an estimated $1.96K and bringing the position to 1,126 shares worth $249K. The position accounts for 0.01% of the portfolio, ranked #667.

Bailard first reported a position in STE in Q1 2024 and has held it in 9 quarters since. The position peaked at $283K in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Bailard held 1,126 shares of Steris worth $249K as of Q1 2026.
  • Bailard bought 8 Steris shares in Q1 2026, an estimated $1.96K.
  • Steris made up 0.01% of Bailard's portfolio in Q1 2026, its #667 holding.
  • Bailard first reported a position in Steris in Q1 2024 and has held it in 9 quarters since.
  • Bailard's Steris position peaked at $283K in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.